News by subject: LICENSING AGREEMENTS

Arbutus Biopharma Corporation , an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that a justice of the Court of Appeal for British Columbia denied an attempt by Acuitas Therapeutics to appeal the injunction...

DHX Media (or the "Company") , the world's leading independent, pure-play children's content company, has signed nine new distribution deals for the first season of the animated series, Fangbone! (50 x 11'). Linear broadcasters newly signed...

Ener-Core, Inc. , a developer and licensor of innovative gas conversion technologies for global commercial and industrial facilities, and the Dresser-Rand business, part of Siemens Power and Gas Division, have amended their June 2016 Commercial and...

Belo Sun Mining Corp. ("Belo Sun" or the "Company") has received an interim suspension order issued by a judge from the Brazilian Federal Regional Court (the "Court") related to the Construction Licence ("LI") for the Volta Grande Project. According...

RedHill Biopharma Ltd. (Tel-Aviv Stock Exchange:RDHL) (?RedHill? or the ?Company?), a specialty biopharmaceutical company primarily focused...

The Centre for the Commercialization of Antibodies and Biologics (CCAB), through the University of Toronto, has granted a non-exclusive license to Pionyr Immunotherapeutics encompassing an undisclosed number of antibody programs in Pionyr's...

BlackBerry Limited today shared new details on its broad licensing strategy which addresses the growing need for secure, connected devices and endpoints in today's Enterprise of Things.  The first phase of BlackBerry's strategy, announced...

Bionik Laboratories Corp. (?Bionik? or the "Company"), a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home, announced today that it has entered...

Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") announces that its wholly-owned subsidiary 7 ACRES has received a renewal of its license to cultivate cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations...

Aequus Pharmaceuticals Inc. ("Aequus" or the "Company") announced today that through a previously announced Research Service Contract with Transdermal Research Pharma Lab ("TRPL") it has entered into a binding term sheet (the "Term Sheet") to...

Dundee Sustainable Technologies Inc. ("DST")  is pleased to announce that it has entered into an agreement with a Canadian exploration company (the "Company") to conduct a pilot scale test program on samples from the Company's gold project (the...

DHX Media (or the "Company") , the world's leading independent, pure-play children's content company, has licensed more than three-dozen kids' series to Amazon Prime Video's new subscription-video-on-demand (SVOD) service in India. Thom Chapman,...

Matic Insurance Services, Inc., the nation's leading digital homeowner's insurance agency for mortgage borrowers, announced that Academy Mortgage Corporation has acquired the source code of Matic Home, the company's secure web- and mobile-based...

A leader in software development and software quality, Askida is proud to announce that it has obtained the most recent ISO 9001 certification, ISO 9001:2015. Located in Montreal, Askida underwent an external audit conducted by an independent quality...

Research Frontiers and NSG UMU Products Co., Ltd. announced today that UMU Products has acquired a license from Research Frontiers Inc. to produce and sell SPD-SmartGlass architectural intelligent products throughout the United States, Canada,...

ViaDerma, Inc. , a specialty pharmaceutical company devoted to bringing new products to market, announced today that on December 14th, 2016, CEO Dr. Christopher Otiko filed a patent application with the USPTO for its proprietary innovative...

Golden Leaf Holdings Ltd. ("GLH" or the "Company") , a leading cannabis oil solutions company built around recognized brands, today announced that the Company received its OLCC (Oregon Liquor Control Commission) recreational processor and wholesaler...

VIVUS, Inc. and Selten Pharma, Inc., announced VIVUS' acquisition from Selten of exclusive, worldwide rights for the development and commercialization of tacrolimus and ascomycin for the treatment of Pulmonary Arterial Hypertension (PAH) and related...

Amunix Operating Inc. announced today that Biogen has exercised its option to enter into an exclusive, worldwide license agreement to develop and commercialize a novel, recombinant Factor IX product candidate that incorporates Amunix' XTEN...